Armata Pharmaceuticals Stock Price - ARMP

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Armata Pharmaceuticals Inc ARMP AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.155 3.87% 4.165 4.20 4.036 4.10 4.01 20:00:00
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
84 7,927 $ 4.11 $ 32,610 7,338 2.45 - 5.00
Last Trade Time Type Quantity Stock Price Currency
20:00:00 100 $ 4.165 USD

Armata Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 41.38M 9.93M -9.24 - 9.34M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
132.64k $ - 0.00% 1.00 6.00%

more financials information »

Armata Pharmaceuticals News

Loading Messages....

Latest ARMP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARMP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.504.653.95034.3514,615-0.335-7.44%
1 Month4.144.653.95034.287,6730.0250.6%
3 Months4.354.853.404.178,943-0.185-4.25%
6 Months3.275.002.453.8937,0440.89527.37%
1 Year4.905.002.453.8937,922-0.735-15.0%
3 Years4.905.002.453.8937,922-0.735-15.0%
5 Years4.905.002.453.8937,922-0.735-15.0%

Armata Pharmaceuticals Description

Armata Pharmaceuticals Inc is a clinical-stage biotechnology company focused on improving human health through the development of novel natural and synthetic bacteriophage-based therapies to treat multidrug-resistant bacterial infections and preventable infectious disease of the microbiome. Its product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains.

Your Recent History
Armata Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.